ABTRAYGE Trademark

Trademark Overview

On Tuesday, July 27, 2021, a trademark application was filed for ABTRAYGE with the United States Patent and Trademark Office. The USPTO has given the ABTRAYGE trademark a serial number of 79318857. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by APROGEN INC.. The ABTRAYGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, biological preparations for the treatment of cancer; medicines for human purposes in the nature of anti-cancer medicines; anti-cancer preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
abtrayge

General Information

Serial Number79318857
Word MarkABTRAYGE
Filing DateTuesday, July 27, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6966018
Registration DateTuesday, January 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements

Goods and ServicesPharmaceuticals, namely, biological preparations for the treatment of cancer; medicines for human purposes in the nature of anti-cancer medicines; anti-cancer preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPROGEN INC.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR
Party NameAPROGEN INC.
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressKR
Party NameAPROGEN INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameAPROGEN INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 4, 2023FINAL DISPOSITION PROCESSED
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, January 1, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, December 28, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, December 21, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, December 9, 2022CHANGE OF OWNER RECEIVED FROM IB
Monday, November 14, 2022NOTIFICATION PROCESSED BY IB
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 5, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 22, 2022REFUSAL PROCESSED BY IB
Tuesday, May 31, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 31, 2022REFUSAL PROCESSED BY MPU
Tuesday, April 26, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 25, 2022NON-FINAL ACTION WRITTEN
Friday, April 22, 2022ASSIGNED TO EXAMINER
Tuesday, September 7, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

abtrayge cancer preparations pharmaceutical anti medicines treatment namely substances prevention biological